Form 4: Medpace Executive Sells 10,000 Shares for $4.8M
Insider Transaction Report
Medpace Holdings, Inc. Executive Vice President of Operations, Susan E. Burwig, sold 10,000 shares of common stock for approximately $4.8 million.
Summary
- Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc. (MEDP), disposed of 10,000 shares of common stock.
- The transaction occurred on September 3, 2025, at a weighted average price of $480 per share.
- The total value of the shares sold is approximately $4,800,000.
- Following this sale, Ms. Burwig directly owns 57,500 shares of Medpace common stock.
- The sale was executed pursuant to a limit order placed by Ms. Burwig during an open window period.
Sentiment
Score: 5
Explanation: The filing reports a routine insider sale by an executive. While a sale can sometimes be perceived negatively, it is a common occurrence for personal financial planning and portfolio diversification and does not inherently indicate a negative outlook for the company based solely on this filing.
Positives
- NA
Negatives
- A high-ranking executive, Susan E. Burwig, sold a significant number of shares (10,000) in Medpace Holdings, Inc., which could be interpreted by the market as a signal of reduced confidence or a belief that the stock is fully valued.
Risks
- Potential for negative market perception or short-term stock price volatility due to a significant insider sale by a key executive.
Future Outlook
NA
Industry Context
NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: May interpret the executive's sale as a signal, potentially influencing short-term market sentiment and stock price.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 09/03/2025 | Date of earliest transaction (sale of common stock by Susan E. Burwig) |
| 09/05/2025 | Signature date of the reporting person's attorney-in-fact for the Form 4 filing |
Recommendation
holdAn executive's sale of shares is a common event for personal financial management and portfolio diversification. While it can sometimes be viewed negatively by the market, this single transaction, without further context on company performance or strategic shifts, does not provide sufficient grounds for a definitive 'buy' or 'sell' recommendation. Investors should 'hold' and monitor future filings and company news for a more comprehensive view.
Keywords
Medpace Holdings, MEDP, insider trading, Form 4, stock sale, executive transaction, Susan E. Burwig, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.